Literature DB >> 15735404

Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration.

Dinender Kumar1, Timothy J Kamp, Martin M LeWinter.   

Abstract

Many forms of heart disease are associated with the loss of cardiomyocytes both via apoptosis or necrosis, and despite the recent identification of resident cardiac stem cells, the native capacity for renewal and repair is inadequate. Cell transplantation strategies have emerged as a potential therapeutic approach for repairing injured myocardium. Many different cell types including embryonic stem cells have been transplanted in myocardial infarction (MI) models with resulting improvement in myocardial function. Here, we review the current state of knowledge with regard to the potential of embryonic stem (ES) cells to differentiate into cardiomyocytes in the embryonic stem cell derived-embryoid body (EB) in vitro system as well as for myocardial regeneration following myocardial infarction.

Entities:  

Mesh:

Year:  2005        PMID: 15735404     DOI: 10.1097/00019501-200503000-00006

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  10 in total

Review 1.  Stem cells in the infarcted heart.

Authors:  Dinender K Singla
Journal:  J Cardiovasc Transl Res       Date:  2009-11-20       Impact factor: 4.132

Review 2.  Very small embryonic-like stem cells: biology and therapeutic potential for heart repair.

Authors:  Ewa K Zuba-Surma; Wojciech Wojakowski; Mariusz Z Ratajczak; Buddhadeb Dawn
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

3.  Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization.

Authors:  Sumbul Fatma; Donald E Selby; Reetu D Singla; Dinender K Singla
Journal:  Antioxid Redox Signal       Date:  2010-07-28       Impact factor: 8.401

Review 4.  Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Authors:  Kalpana Mujoo; Joshua S Krumenacker; Ferid Murad
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

5.  TGF-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium.

Authors:  Dinender K Singla; Reetu D Singla; Stephanie Lamm; Carley Glass
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-04       Impact factor: 4.733

Review 6.  Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration.

Authors:  Debayon Paul; Samson Mathews Samuel; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 7.  Embryonic stem cells in cardiac repair and regeneration.

Authors:  Dinender K Singla
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 8.  Non-coding RNAs in cardiac regeneration.

Authors:  Lichan Tao; Yihua Bei; Yanli Zhou; Junjie Xiao; Xinli Li
Journal:  Oncotarget       Date:  2015-12-15

9.  Mitochondrial pyruvate dehydrogenase phosphatase 1 regulates the early differentiation of cardiomyocytes from mouse embryonic stem cells.

Authors:  Hye Jin Heo; Hyoung Kyu Kim; Jae Boum Youm; Sung Woo Cho; In-Sung Song; Sun Young Lee; Tae Hee Ko; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Exp Mol Med       Date:  2016-08-19       Impact factor: 8.718

10.  Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches.

Authors:  L M Popescu; Mihaela Gherghiceanu; C G Manole; Maria Simonetta Faussone-Pellegrini
Journal:  J Cell Mol Med       Date:  2009-04-20       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.